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Introduction
Natural killer (NK) cells are critical in the first line defense of the immune system against viral infections 1 . 12, 13 , and changes in cytokine secretion 6, 14, 8, 15 . Overall, these data suggest significant changes within the NK cell compartment in chronic viremic HIV-1 infection. However, little is known about the NK cell compartment during acute infection, and the kinetics of these deregulations. Here we report that distinct changes in the NK cell compartment start in acute HIV-1 infection, progressively leading to a depletion of functionally active NK cells. 
Material and Methods

Study Subjects
Sixty-nine subjects were included in this study, including 14 HIV-1 uninfected controls, 45 subjects with chronic HIV-1 infection, and 10 with acute HIV-1 infection (Table 1) . Acute infection was defined by a negative HIV-1 Elisa or a positive Elisa but less than three bands in an HIV-1 western blot in the presence of detectable HIV-1 RNA.
Of the 45 subjects with chronic infection, 11 were successfully treated with HAART for at least 6 months ("treated aviremic"), 9 individuals were treated with HAART but not fully virologically suppressed ("treated viremic"), 14 subjects were untreated and had progressive HIV-1 infection ("untreated viremic"), and 11 subjects had non-progressive chronic infection defined by controlled viral replication in the absence of HAART for more than 6 years ( Table 1 ).
The MGH Institutional Review Board approved the study and each subject gave informed consent for participation in the study.
Flow cytometric analysis of intracellular cytokine production and CD107a
NK cell sub-populations were defined by the expression of CD3, CD56 and CD16. The frequency of degranulating (CD107a expression) and IFN-γ secreting NK cells was quantified by multi-parameter intracellular cytokine staining, as described previously 8, 16 .
A response was considered positive if the frequency of CD107a expressing or cytokine secreting stimulated NK cells was at least three fold greater than in unstimulated controls 16 .
For
Statistical Analysis:
Differences between multiple groups were performed using a one-way ANOVA with a Tukey's correction. were observed among the groups of subjects with chronic infection or uninfected controls ( figure 1A ). In contrast, the total proportion of NK cells in subjects with acute HIV-1 infection was significantly increased (figure 1A, p<0.05 for all comparisons). Taken together, these data suggest that the overall NK cell population is expanded during acute HIV-1 infection, but returns to levels similar to those seen in HIV-1 uninfected controls in subjects with chronic HIV-1 infection. 
Functional differences among the three subsets of NK cells in chronic HIV-1 infection
To further elucidate the functional properties of these 3 subsets of NK cells, we evaluated the ability of the different subsets to recognize MHC devoid target cells ( figure   2A and B) and to respond to mitogenic stimulation in chronic infection(figure 2C and D) figure 2A and B) . In contrast, both figure 1A and B). This observation was associated with an elevated expression of KIR molecules on NK cells in viremic as compared to aviremic subjects (63% vs 34%, p<0.001) 4 . In contrast, the ability of NK cells to respond to PMA/ionomycin was severely compromised in subjects with chronic progressive infection, whereas the ability to respond to this stimulus appeared to be unimpaired in non-progressors (p <0.001). These data demonstrate a differential impact of persistent viremia on the NK cell response, resulting in an increased ability to respond to stimulation with K562 cells associated with increased KIR expression, but an overall reduced responsiveness to stimulation with mitogen. Overall, we observed an early loss pos (white) NK cells for all HIV-1 infected chronic groups, controls, and acute HIV-1 infected subjects. Numbers indicate the median percentage. C) Whisker box plots depict the distribution of the three NK cell subsets following one year of follow-up for 5 subjects that received antiretroviral therapy in acute HIV-1 infection and 5 subjects that remained off therapy. 
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